Pharmafile Logo

SCM Pharma

SCM Pharma is a contract development & manufacturing organisation (CDMO) that develops and makes novel, difficult and dangerous drugs on behalf of our clients. Our formulation development, cGMP manufacturing and aseptic processing services include the sterile filling of liquids, gels and powders (including flammable products) into a range of final dosage forms including ampoules, vials, cartridges, syringes and bottles. So if you’re a pharmaceutical, biotech, medical device or healthcare institution in need of formulation development, clinical manufacturing or contract filling involving a complex product or process – let’s talk.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Unit 6 Regents Drive, Low Prudhoe Industrial Estate, Prudhoe, Northumberland, NE42 6PX, United Kingdom
+44(0) 1661 833 693

 Latest Content from PMHub 

Lucid Group celebrates a fang-tastic Halloween

Last week the Lucid charity working group, Lucid SPIRIT, organised a fang-tastic Halloween Bingo evening to raise money for its charity partner, Wycombe Homeless Connection (WHC).Lucidians went to town with...

OPEN Health announces the integration of Pharmerit International into the group

Press Releases | November 4, 2019 | OPEN Health

OPEN Health has today announced the integration of Pharmerit International, a global leader in health economics and outcomes research (HEOR), into its group of companies.

Article: Market access in Brazil

White Papers and Resources | November 1, 2019 | Inizio

All eyes on Spinraza

China: How to strategise and win in the world’s fastest changing healthcare market

White Papers and Resources | November 1, 2019 | Inizio

In this paper, experts Marc Yates, Pei Li Teh and Brett Gardiner discuss the China healthcare reforms which affect pharma and propose how to build the market understanding required to launch...

How ready are you for launch?

Pharmaceutical launches are becoming more complex and competitive. Our launch excellence diagnostic tool helps you to map how ready you are for launch, while facilitating success in this challenging environment.

Does your pre-launch strategy really drive behaviour change?

One of the most interesting parts of a pharmaceutical launch is delving into the minds of stakeholders to understand why they behave in the way that they do. Blue Latitude...

Digitalising healthcare: what can the NHS learn from other industries?

Expensive digital solutions are often disregarded because they do not work well for the end user. Account Manager Fiona Grace explores this challenge and reveals the stories of innovation we...

OPEN Health mobilised to support outcomes with gene and other advanced therapies

Harnessing the power of collaborations to bring real insights and improve outcomes

UK vs US: what makes a successful immunisation programme?

Emily Macdonald calls on her experience as a public health nurse specialising in the prevention of infectious disease in both the US and UK, to explore the differences between immunisation...